BioSpace News Archive

FDA

Vertex Announces U.S. FDA Approval for TRIKAFTA® (elexacaftor/tezacaftor/ivacaftor and ivacaftor) in Children With Cystic Fibrosis Ages 6 through 11 With Certain Mutations

Vertex Announces U.S. FDA Approval for TRIKAFTA ® in Children With Cystic Fibrosis Ages 6 through 11 With Certain Mutations.

June 9, 2021
·
9 min read
Pharm Country

Halberd Corporation Undertakes Process Toward the Elimination of Alzheimer’s Disease

Halberd Corporation (OTC PINK:HALB) commences experimentations to eradicate three of the principal components of Alzheimer’s Disease.

June 9, 2021
·
5 min read
Genetown

Syros Pharmaceuticals to Present at JMP Securities 2021 Life Sciences Conference

Syros Pharmaceuticals today announced that its Chief Executive Officer, Nancy Simonian, M.D., will participate in a fireside chat at the JMP Securities 2021 Life Sciences Conference.

June 9, 2021
·
1 min read
Biotech Bay

Pulse Biosciences Announces Health Canada Approval for CellFX® System

Pulse Biosciences Announces Health Canada Approval for CellFX ® System - Company to Expand Global Controlled Launch Program with Clinical Aesthetic Experts in Canada.

June 9, 2021
·
5 min read
Pharm Country

CorMedix Inc. to Participate in Fireside Chat at the JMP Securities Life Sciences Conference

CorMedix Inc. (Nasdaq: CRMD), today announced that CorMedix management will participate in a fireside chat at the JMP Securities Life Sciences Conference taking place on June 16 – 17, 2021.

June 9, 2021
·
2 min read
Business

Revolo Biotherapeutics Enters into Partnership Agreement with Northway Biotech to Manufacture its Novel Binding Immunoglobulin Protein, ‘1805, to Support Phase 2 Trials in Rheumatoid Arthritis and Uveitis

Revolo Biotherapeutics (“Revolo Bio” or the “Company”), announced today that it has entered into a partnership with Northway Biotech, to manufacture its binding immuno-regulatory protein, ‘1805.

June 9, 2021
·
4 min read
Pharm Country

Aquestive Therapeutics to Participate in JMP Securities and BMO Capital Market Investor Conferences

Aquestive Therapeutics, Inc. (NASDAQ: AQST), a pharmaceutical company focused on developing and commercializing differentiated products that address patients’ unmet needs and solve therapeutic problems, announced today that the management team will participate in two upcoming investor conferences in June.

June 9, 2021
·
7 min read
Business

SyntheticMR enters joint development project with Juntendo University Hospital and Canon Medical Systems

SyntheticMR announced today that they have entered a development project together with Juntendo University Hospital, based in Tokyo, Japan, and Canon Medical Systems.

June 9, 2021
·
1 min read
Business

Health Logic Interactive Announces Appointment of Scientific Advisory Board Members and First Virtual Meeting

Health Logic Interactive Inc. (“Health Logic” or the “Company”) (TSXV: CHIP.H) (OTCPK: CHYPF) is pleased to announce the addition of new members to its Scientific Advisory Board (“SAB”) including nephrology specialists Dr. Adeera Levin from the University of British Columbia, Dr. Lesley Inker of Tufts Medical Center, and Dr. Susan Quaggin of Northwestern University.

June 9, 2021
·
4 min read
Business

Heart & Vascular Center at Valley View Offers Open Heart Surgery and New Cardiothoracic Procedures, Under the Leadership of Cardiothoracic Surgeon Stephen Jones, MD

The Heart & Vascular Center at Valley View is pleased to introduce new services to continue to provide patients with world-class, convenient and compassionate care on the Western Slope.

June 9, 2021
·
4 min read